Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2004
06/09/2004CN1502626A Novel human protein with cancer-inhibiting function and coding sequence thereof
06/09/2004CN1502625A Oligopeptide suppressor of matrix metalloprotease 2
06/09/2004CN1153064C Method of enriching rare cells
06/09/2004CN1152965C Method of quantitative measurement of gene expression using mutiplex competitive reverse transcriptase-polymerase chain reaction
06/09/2004CN1152962C Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization
06/09/2004CN1152961C Transcription factor controlling phenylpropanol biosynthesis pathway
06/09/2004CN1152960C ICAM-4 materials and methods
06/09/2004CN1152959C Fully synthetic insecticidal crystal protein gene of Bacillus thuringiensis
06/09/2004CN1152957C Human 6-phosphoglucosamine isomerase, its code sequence and application
06/09/2004CN1152956C Hydantoin hydrolae and its application
06/09/2004CN1152955C Process for producing protease
06/09/2004CN1152871C Hydroxylamine derivative useful for enhancing molecular chaperon prodn. and the prep. thereof
06/08/2004US6748265 Electrode apparatus and method for the delivery of drugs and genes into tissue
06/08/2004US6747190 Xyloglucan fucosyltransferase plants transformed with a DNA encoding arabidopsis
06/08/2004US6747189 Maize glycine rich protein promoter compositions and methods for use thereof
06/08/2004US6747188 Nucleotide sequences for use in the generation of disease resistant plants
06/08/2004US6747187 Knockout mouse for the tumor suppressor gene ANX7
06/08/2004US6747141 Methods and compositions for detection of mycobacterium avium complex species
06/08/2004US6747136 Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen
06/08/2004US6747134 Antibody immunologically reactive with serine protease EOS
06/08/2004US6747130 Tenebrio antifreeze proteins
06/08/2004US6747014 For therapy of inflammatory bowel disorder
06/08/2004US6747013 Such as rheumatoid arthritis; gene therapy, such as to replace a defective apoptotic gene, to cells in the affected area
06/08/2004US6747007 Cationic, polyphemusin-like peptides
06/08/2004US6747005 Determining importin alpha activities in presence and absence of camp-response element binding protein which acetylates importin alpha to determine effect on activities, comparing effect in presence and absence of test compound
06/08/2004US6747004 Contacting embryonic forebrain cells in vitro with amount of endometrial bleeding associated factor protein having specified amino acid sequence effective to induce proliferation of forebrain cells
06/08/2004US6747003 Modified vitamin K-dependent polypeptides
06/08/2004US6746871 Bacillus crystal proteins having improved insecticidal activity; immunodetection kits; transgenic plants
06/08/2004US6746870 DNA recombination in eukaryotic cells by the bacteriophage PHIC31 recombination system
06/08/2004US6746869 Electrospraying apparatus and method for coating particles
06/08/2004US6746868 Chemical modification of DNA using peptide nucleic acid conjugates
06/08/2004US6746867 Mammalian mesoderm induction early response (MIER) gene family
06/08/2004US6746865 Nucleic acids encoding for endostatin protein
06/08/2004US6746861 Human kinase protein and polynucleotides encoding the same
06/08/2004US6746860 Paramyxovirus vectors used for transfer of foreign genes
06/08/2004US6746855 L-lysine-producing corynebacteria and process for the preparation of L-lysine
06/08/2004US6746854 Nucleotide sequences coding enzymatic polypeptide for use genration of amino acids
06/08/2004US6746853 Proteins with insulin-like activity useful in the treatment of diabetes
06/08/2004US6746845 Oligonucleotide for use as diagnostic tool in genetic engineering
06/08/2004US6746844 Determining signal transduction pathways
06/08/2004US6746843 Methods of screening novel agents for use in cancer therapy and prevention
06/08/2004US6746841 FTA- coated media for use as a molecular diagnostic tool
06/08/2004US6746840 Micro array and analyzing method using the same
06/08/2004US6746838 Protein which is capable of binding to any predefined nucleic acid sequence
06/08/2004US6746837 Multiple drug resistance gene atrD of aspergillus nidulans
06/08/2004US6746672 Isolated bifidobacteria that produce siderophores which inhibit growth of lactococcus lactis
06/08/2004US6746608 Use of adsorbent polymer particles in DNA separation
06/08/2004US6746441 Applying multiple series of three step (collection, electro-poration, electrophoresis) pulses to cell
06/08/2004CA2262884C Egf-like factor from chromaffin granules and glia cell-derived neurotrophic factor with survival-promoting activity on daergic neurons
06/08/2004CA2261020C Preparation of pichia methanolica auxotrophic mutants
06/08/2004CA2064814C Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof
06/08/2004CA2023888C Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
06/03/2004WO2004046387A1 Methods and compositions for analysis of regulatory sequences
06/03/2004WO2004046379A1 Nucleic acid probes and broad-range primers from regions in topoisomerase genes, and methods in which they are used
06/03/2004WO2004046376A2 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll)
06/03/2004WO2004046373A2 Promoter variants for expressing genes in a fungal cell
06/03/2004WO2004046365A2 Interferon-alpha polypeptides and conjugates
06/03/2004WO2004046363A1 Induced humoral immune response using promoters specifically active in antigen presenting cells
06/03/2004WO2004046362A2 Hydroxypyruvate reductase promoter elements and methods of use thereof in plants
06/03/2004WO2004046361A1 Method of controlling a cellular process in a multi-cellular organism
06/03/2004WO2004046360A2 Method of controlling cellular processes in plants
06/03/2004WO2004046359A2 Method of controlling gene expression in plants or plant cells
06/03/2004WO2004046358A1 Novel cancer-associated gene
06/03/2004WO2004046357A1 Organ preferential genes identified by t-dna insertional mutagenesis of rice
06/03/2004WO2004046356A1 EXON 1β OF PDGF RECEPTOR α GENE AND UTILIZATION THEREOF
06/03/2004WO2004046355A2 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof
06/03/2004WO2004046354A1 Oligoribonucleotides for treating degenerative skin disorders by rna interference
06/03/2004WO2004046353A1 Method of isolating nucleic acid having desired functional property and kit therefor
06/03/2004WO2004046350A1 ROTARY MOTOR MOLECULE V1-ATPase
06/03/2004WO2004046348A1 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders
06/03/2004WO2004046347A1 Method for producing riboflavin
06/03/2004WO2004046346A2 Self-containing lactobacillus strain
06/03/2004WO2004046341A2 Modulation of kiaa0415 expression
06/03/2004WO2004046340A2 Intron fusion construct and method of using for selecting high-expressing production cell lines
06/03/2004WO2004046339A2 Caged sensors, regulators and compounds and uses thereof
06/03/2004WO2004046336A2 Production of increased oil and protein in plants by the disruption of the phenylpropanoid pathway
06/03/2004WO2004046335A2 A method for cloning of a rare, specifically mutated cell
06/03/2004WO2004046332A2 Amplified genes involved in cancer
06/03/2004WO2004046330A2 Methods of generating high-production of antibodies from hybridomas created by in vitro immunization
06/03/2004WO2004046327A2 Inhibitory oliogonucleotides targeted to bcl-2
06/03/2004WO2004046326A2 Modulation of interleukin 22 receptor expression
06/03/2004WO2004046325A2 Modulation of serine/threonine kinase 16 expression
06/03/2004WO2004046324A2 Allele-targeted rna interference
06/03/2004WO2004046321A2 Cis/trans riboregulators
06/03/2004WO2004046320A2 METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS
06/03/2004WO2004046318A2 Improved clonal cell lines derived from bti-tn-5b1-4
06/03/2004WO2004046317A2 Products and processes for modulating peptide-peptide binding domain interactions
06/03/2004WO2004046313A2 Methods and compositions for determining methylation profiles
06/03/2004WO2004046310A2 Novel mouse polypeptides encoded by polynucleotides and methods of their use
06/03/2004WO2004046305A2 Method and system for cell and/or nucleic acid molecules isolation
06/03/2004WO2004046231A1 Dna isolation material and method
06/03/2004WO2004046197A2 Genes for galactomannan production in plants and methods of use
06/03/2004WO2004046191A2 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition angiogenesis
06/03/2004WO2004046190A2 Antibodies lacking vacuolar targeting signal peptide and capable of binding j-chain
06/03/2004WO2004046189A2 Method for generating immunoglobulin genes
06/03/2004WO2004046188A2 Anti-activated ras antibodies
06/03/2004WO2004046185A2 Intracellular antibodies
06/03/2004WO2004046180A2 Chemosensitization by a non-apoptogenic heat shock protein 70-binding apoptosis inducing factor mutant add70
06/03/2004WO2004046179A1 Tyrosine phosphorylation-deficient mutant calmodulin, production method thereof and use of same in biological methods
06/03/2004WO2004046176A1 Vaccine against hcv